29 April 2022>: Clinical Research
Evaluation of a Precision Approach to Intraoperative Ropivacaine Nerve Block to Improve Postoperative Analgesia in 120 Patients Undergoing Thyroid Surgery
Yong Wang 1B* , Jiankang Shen 1BCFG* , Rongli Xie 1AE , Dan Tan 1E , Xiaoli Jin 1BCD , Liang Shen 2BCD* , Jianming Yuan 1ABCDEF*DOI: 10.12659/MSM.935563
Med Sci Monit 2022; 28:e935563
Table 2 The effect of precision intraoperative ropivacaine nerve block on visual analogue scale (VAS) scores. The VAS was performed at 2 h, 6 h, and 24 h after surgery was completed. Visual Analogue Score (VAS).
Time after the surgery | Precision group | Tradition group | Control group | P | ||
---|---|---|---|---|---|---|
2 h | Sex | Male | 1.5±0.6 | 1.7±0.6 | 3.3±1.1 | 0.001 |
Female | 1.4±0.5 | 1.6±0.5 | 2.6±1.0 | |||
0.717 | 0.587 | 0.035 | ||||
Diagnosis | Benign | 1.3±0.6 | 1.6±0.6 | 2.6±1.2 | 0.017 | |
Malignant | 1.4±0.7 | 1.7±0.7 | 2.9±1.1 | |||
0.821 | 0.651 | 0.726 | ||||
Scope | Unilateral | 1.4±0.6 | 1.5±0.6 | 2.5±0.9 | ||
Bilateral | 1.5±0.6 | 1.7±0.7 | 3.3±1.1 | |||
0.225 | 0.198 | 0.020 | ||||
6 h | Sex | Male | 1.1±0.6 | 1.2±0.6 | 2.6±1.1 | 0.005 |
Female | 1.0±0.5 | 1.1±0.5 | 2.6±1.0 | |||
0.741 | 0.572 | 0.915 | ||||
Diagnosis | Benign | 1.0±0.5 | 1.1±0.6 | 2.4±1.2 | 0.012 | |
Malignant | 1.0±0.6 | 1.2±0.5 | 2.7±1.2 | |||
0.851 | 0.632 | 0.520 | ||||
Scope | Unilateral | 0.9±0.4 | 1.1±0.5 | 2.4±1.0 | ||
Bilateral | 1.1±0.6 | 1.2±0.6 | 2.7±1.2 | |||
0.362 | 0.542 | 0.261 | ||||
24 h | Sex | Male | 0.8±0.4 | 0.7±0.5 | 2.0±1.0 | 0.001 |
Female | 0.7±0.3 | 0.6±0.4 | 1.8±0.9 | |||
0.861 | 0.675 | 0.545 | ||||
Diagnosis | Benign | 0.7±0.4 | 0.5±0.5 | 1.8±1.0 | 0.010 | |
Malignant | 0.7±0.4 | 0.6±0.4 | 2.0±1.0 | |||
0.914 | 0.532 | 0.468 | ||||
Scope | Unilateral | 0.7±0.3 | 0.5±0.4 | 1.8±0.8 | ||
Bilateral | 0.7±0.5 | 0.6±0.4 | 2.0±1.0 | |||
0.875 | 0.453 | 0.432 |